#USA #Solon #HospiceChoice Rx #Shelly Mikuls #NaviScript

HospiceChoice Rx Welcomes Shelly Mikuls as New Director of Business Development

In an exciting development for the healthcare sector, HospiceChoice Rx has recently announced the hiring of Shelly Mikuls as its new Director of Business Development. This appointment, effective January 2025, is expected to create new opportunities and strengthen the company's service offerings in hospice and palliative care.

Shelly Mikuls is not new to the hospice landscape. With over 17 years of dedicated experience, including six years with a hospice pharmacy benefit manager (PBM), Mikuls brings a wealth of knowledge in both clinical practices and operational management. Her extensive background will play a significant role in enhancing relationship-building efforts with electronic medical record (EMR) partners and provide education on the innovative NaviScript ePrescribing platform that the company offers.

Background and Experience

Mikuls has a robust educational foundation with a master’s degree from Washington University’s George Warren Brown School of Social Work. Her career journey began in long-term care and steadily progressed into pivotal leadership roles, such as the Executive Director at a start-up hospice and the Manager of Support Services at a hospice PBM. Her broad spectrum of experiences has endowed her with a deep understanding of the intricate nature of hospice operations, particularly in helping clients navigate their daily challenges in patient care.

Mikuls is also well-versed in the Centers for Medicare and Medicaid Services (CMS) accreditation processes and current regulatory guidelines, which positions her as a key asset for HospiceChoice Rx.

Company Statement

Nick Opalich, the CEO of HospiceChoice Rx, expressed enthusiasm about Mikuls’ addition to the team, stating, "We are excited to welcome Shelly to our team in 2025 to start the year with new opportunities. She brings a wealth of experience to our team with a diverse background in hospice management." This sentiment highlights the company’s commitment to prioritizing education programs for hospice providers and its overarching goal of enhancing care teams' training initiatives.

Focus on Innovative Solutions

HospiceChoice Rx has been at the forefront of modernizing pharmacy benefits exclusively for hospice and palliative care organizations. With a relentless commitment to expanding their services across the nation, the company has developed NaviScript, a state-of-the-art technology designed to streamline the prescription ordering process, allowing healthcare providers to focus more on patient care rather than administrative tasks.

Mikuls herself comments on this innovative approach, stating, "I believe that my knowledge and experience pair well with HospiceChoice Rx's innovative approach to hospice PBM services and will lead to improved clinical outcomes and efficiencies." Her vision aligns perfectly with the company’s mission to focus on the unique needs of hospice services while integrating new technologies that yield tangible benefits.

Commitment to Patient Care

With a vision to improve prescribing workflows, HospiceChoice Rx is dedicated to providing solutions that expedite access to medications for hospice patients. The company boasts a nationwide pharmacy network comprising over 75,000 pharmacies, ensuring effective medication access regardless of patients’ residences. Furthermore, they are committed to upholding established relationships with preferred local pharmacies.

HospiceChoice Rx continues to resonate as a gamechanger in the hospice industry, aiming to create sustainable cost-saving opportunities while ensuring that patients receive the highest quality of care. As Mikuls joins the team, her insights and expertise will undoubtedly lead to significant advancements in the company’s service offerings and enhance their strategic initiatives going forward.

For more information about HospiceChoice Rx and their services, visit www.hospicechoicerx.com.